In a bid to give a fillip to the vaccination efforts against COVID-19 in India, Tata Medical & Diagnostics is engaging with multiple vaccine makers like Johnson & Johnson (J&J) and AstraZeneca for marketing and distribution deals, Economic Times.
Furthermore, the company is already tapping in on the network of pharmacy e-commerce platform 1mg which the Tata Group is in the process of acquiring. The company is leveraging 1mg's network as it plans to enter the COVID-19 vaccination after 1 May when the scope will be opened up to the private sector enterprises.
The company has also involved 1mg's chief executive Prashant Tandon in the discussions on its vaccination plans.
The company is presently said to be ironing out the specifics to cover the vaccination of its six lakh employees, trade partners, vendors and also to parallelly offer vaccinations to others. 1mg will likely be handling the job of testing and vaccinations for the Tata Group entity.
It should be noted that the Tata Group incorporated the Tata Medical & Diagnostics in June last year amid the pandemic, as the group looked to cater to the COVID-19 health requirements in the devices and formulations space.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.